LifeStance Health Group, Inc. (LFST)
收市後：
| 前收市價 | 6.86 |
| 開市 | 6.97 |
| 買盤 | 6.88 x 500 |
| 賣出價 | 6.94 x 200 |
| 今日波幅 | 6.84 - 6.98 |
| 52 週波幅 | 4.64 - 9.20 |
| 成交量 | |
| 平均成交量 | 1,627,931 |
| 市值 | 2.644十億 |
| Beta 值 (5 年，每月) | 1.24 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.41 |
| 業績公佈日 | 2024年8月08日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 7.92 |
ZacksWall Street Analysts Think LifeStance Health (LFST) Could Surge 26.68%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Insider MonkeyLifeStance Health Group, Inc. (LFST): The Best Among Morgan Stanley’s Highest Conviction Stocks
We recently compiled a list of the Morgan Stanley’s Highest Conviction Stocks: Top 20 Stocks To Buy. In this article, we are going to take a look at where LifeStance Health Group, Inc. (NASDAQ:LFST) stands against Morgan Stanley’s other high conviction stocks. With the second half of 2024 having settled in, the broader economic environment that […]
ZacksWall Street Analysts Believe LifeStance Health (LFST) Could Rally 39.38%: Here's is How to Trade
The mean of analysts' price targets for LifeStance Health (LFST) points to a 39.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
